BeiGene Ltd ADR (BGNE)

전일 마감가:

$162.01

열려 있는:

$162.51

하루 거래량:

195.01K

시가총액:

$16.96B

수익:

$2.46B

순이익/손실:

$-881.71M

주가수익비율:

-9.7168

EPS:

-16.6978

순현금흐름:

$-1.75B

1주 성능:

+5.65%

1개월 성능:

+6.78%

6개월 성능:

-11.72%

1년 성능:

-38.77%

1일 변동 폭

$159.25

$162.51

52주 변동 폭

$126.97

$263.15

BeiGene Ltd ADR Stock (BGNE) Company Profile

명칭

BeiGene Ltd ADR

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

345-949-4123

주소

94 Solaris Avenue, Camana Bay, George Town

직원

1,700

트위터

@beigeneusa

다음 수익 날짜

2024-05-08

최신 SEC 제출 서류

BGNE's Discussions on Twitter

BeiGene Ltd ADR Stock (BGNE) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-02-06	재개	JP Morgan	Overweight
2023-09-12	개시	Macquarie	Outperform
2023-08-17	개시	Jefferies	Buy
2023-07-17	개시	Citigroup	Buy
2023-06-30	다운그레이드	Bernstein	Outperform → Mkt Perform
2023-01-12	개시	Daiwa Securities	Buy
2022-10-13	업그레이드	Guggenheim	Neutral → Buy
2022-10-13	업그레이드	SVB Leerink	Mkt Perform → Outperform
2022-08-09	재개	JP Morgan	Overweight
2022-03-17	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2022-02-07	개시	Deutsche Bank	Buy
2021-10-12	개시	Bernstein	Outperform
2021-10-06	업그레이드	CLSA	Underperform → Buy
2021-03-08	개시	China Renaissance	Buy
2021-03-01	다운그레이드	CLSA	Outperform → Underperform
2020-11-09	다운그레이드	Ladenburg Thalmann	Buy → Neutral
2020-11-06	다운그레이드	Maxim Group	Buy → Hold
2020-11-06	다운그레이드	Piper Sandler	Neutral → Underweight
2020-07-10	다운그레이드	CLSA	Buy → Outperform
2020-03-13	업그레이드	Macquarie	Underperform → Neutral
2020-02-18	재개	Goldman	Buy
2020-01-17	업그레이드	CLSA	Outperform → Buy
2020-01-17	재개	Morgan Stanley	Overweight
2019-12-16	다운그레이드	Guggenheim	Buy → Neutral
2019-12-16	다운그레이드	Piper Jaffray	Overweight → Neutral
2019-11-19	다운그레이드	UBS	Buy → Neutral
2019-11-13	다운그레이드	CLSA	Buy → Outperform
2019-11-04	재확인	Maxim Group	Buy
2019-06-04	개시	Bernstein	Outperform
2019-05-10	업그레이드	CLSA	Outperform → Buy
2019-03-15	개시	BofA/Merrill	Buy
2019-01-04	다운그레이드	CLSA	Buy → Outperform
2018-11-21	개시	JP Morgan	Overweight
2018-09-25	개시	Leerink Partners	Outperform
2018-05-17	재확인	Maxim Group	Buy

모두보기

BeiGene Ltd ADR 주식(BGNE)의 최신 뉴스

Evaluating BeiGene: Insights From 6 Financial Analysts

Benzinga

4 Analysts Assess BeiGene: What You Need To Know

Benzinga

Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session

Benzinga

Zymeworks: A Strong Buy Amidst Zanidatamab's Promising Developments

Seeking Alpha

BeiGene Ltd ADR (BGNE) 재무 분석

BeiGene Ltd ADR (BGNE) 매출 2024

BeiGene Ltd ADR (BGNE) 순이익 2024

BeiGene Ltd ADR (BGNE) 현금흐름 2024

BeiGene Ltd ADR (BGNE) 주당 순이익 2024